Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Morepen Laboratories Limited is a pharmaceutical company. The Company operates through four segments; they are Active Pharmaceutical Ingredients (API), Domestic Formulations, Diagnostics and Over the Counter (OTC).
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Please find enclosed copy Srutinizers report of Extraordinary General Meeting held on March 18, 2024 along-with voting results in prescribed format. | Download
Please find enclosed copy Srutinizers report of Extraordinary General Meeting held on March 18, 2024 along-with voting results in prescribed format. | Download
Morepen Laboratories Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on March 18, 2024. Further, the company has informed the Exchange regarding voting results. | Download
Morepen Laboratories Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on March 18, 2024. Further, the company has informed the Exchange regarding voting results. | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant